Cory berkland
BERKLAND LAB TEAM. Our group is made up of extraordinary people that are well versed in the synthesis and characterization of polymers and colloids, validating and quantifying conjugation reactions, and formulating these materials for in vivo applications. They have developed novel approaches for controlling the physicochemical properties of polymers and particles to improve therapeutic ...Amir Fakhari1 and Cory Berkland1,2,3,* 1Bioengineering Graduate Program, University of Kansas 2Department of Pharmaceutical Chemistry, School of Pharmacy, ... [email protected]. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our
Did you know?
Loop is the open research network that increases the discoverability and impact of researchers and their work. Loop enables you to stay up-to-date with the latest discoveries and news, connect with researchers and form new collaborations.Home. Cory Berkland. Distinguished Professor, Pharmaceutical Chemistry. Professor, Chemical & Petroleum Engineering. Contact Info. [email protected]. 785-864-1455. …Acute B-Cell Inhibition by Soluble Antigen Arrays is Valency-Dependent and Predicts Immunomodulation in Splenocytes J. Daniel Griffin1, Martin A. Leon2, Jean R. Salash3, Michael Shao4, Brittany L. Hartwell1, Chad J. Pickens3, Joshua O. Sestak3, Cory Berkland1,3,4 1Bioengineering Graduate Program, University of Kansas, Lawrence, KS 2Department of Chemistry, University of Kansas, Lawrence, KSCory J. Berkland [email protected] Department of Chemical and Petroleum Engineering, University of Kansas, 1530 West 15th Street, Lawrence, KS, 66045 USA. Department of Pharmaceutical Chemistry, University of Kansas, 2095 Constant Avenue, Lawrence, KS, 66047 USA. E-mail: [email protected] Search for more papers by this authorAs an alternative, nanoparticles may be targeted to a specific tissue with up-regulated cell adhesion molecules such as intercellular cell-adhesion molecule-1 (ICAM-1), which is dramatically up-regulated (~10 fold or more) on the vascular endothelium in response to the increased production of proinflammatory cytokines such as interleukin-1-β ...Cory Berkland. The University of Kansas. 在 ku.edu 的电子邮件经过验证. Drug DeliveryFormulationControlled Release. 文章引用次数开放获取的出版物 ...Recipient Qun Wang, and former advisor, Cory Berkland, University of Kansas. Postdoctoral Fellowship Award selection chair Kinam Park (left) and CRS Foundation chair Susan Cady (right) after presenting Qun Wang (center) with the 2010 Jorge Heller Postdoctoral Fellowship.Joshua O Sestak 1 , Bradley P Sullivan 1 , Sharadvi Thati 1 , Laura Northrup 1 , Brittany Hartwell 2 , Lorena Antunez 1 , M Laird Forrest 1 , Charlotte M Vines 3 , Teruna J Siahaan 1 , Cory Berkland 4Cory Berkland The University of Kansas Lawrence, KS. Joel Bernstein New York University Abu Dhabi Abu Dhabi, United Arab Emirates. Michael Blaber Florida State University Tallahassee, FL. Robin H. Bogner University of Connecticut Storrs, CT. Kathleen MK Boje State University of Buffalo Amherst, NY.CORY BERKLAND. Administrator. See All Contacts. Dynamic search and list-building capabilities. Real-time trigger alerts. Comprehensive company profiles. Valuable research and technology reports. Get a D&B Hoovers Free Trial. Financial Data. Dun & Bradstreet collects private company financials for more than 23 million companies worldwide.The aim of this project was to develop a gene replacement therapy for treating Charcot-Marie-Tooth disease type 4C to rescue the phenotype of the Sh3tc2-/- mouse model. We generated a lentiviral vector LV-Mpz.SH3TC2.myc to drive expression of the human SH3TC2 cDNA under the control of the Mpz promoter specifically in myelinating Schwann cells.J. Daniel Griffin, Martin A. Leon, Jean R. Salash, Michael Shao, Brittany L. Hartwell, Chad J. Pickens, Joshua O. Sestak, Cory Berkland. Acute B-Cell Inhibition by Soluble Antigen Arrays Is Valency-Dependent and Predicts Immunomodulation in Splenocytes. Biomacromolecules 2019, 20 (5) , 2115-2122.Nabil A Alhakamy 1 , David T Curiel 2 , Cory J Berkland 3 Affiliations 1 Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia; ... University of Kansas, Lawrence, KS 66047, USA. Electronic address: [email protected]. PMID: 33781953 DOI: 10.1016/j.drudis.2021.03.021 AbstractCory Berkland: Keywords: Pharmacology, Toxicology and Pharmaceutics: Issue Date: 20-Aug-2010: Abstract: Leukemia therapeutics are aiming for improved efficacy by targeting molecular markers differentially expressed on cancerous cells. Lymphocyte function-associated antigen-1 (LFA-1) expression on various types of leukemia has been well …
The AIRR Community Guide to Quality Control: Chain Pairing Precision and Monitoring of Cross-Sample Contamination. Chung C-Y, Gutiérrez-González M, López Acevedo SN, Fahad AS, DeKosky BJ. Immunogenetics: Methods and Protocols, Methods in Molecular Biology, y, (Springer Nature) ISBN: 9781071621141 , 2022. Antibodies Computational immunology ...Cory BERKLAND | Cited by 10,556 | of University of Kansas, Kansas (KU) | Read 249 publications | Contact Cory BERKLANDCory Berkland (BSChE'98) and Devin Shepard (BSChE'97) will receive the 2013 Professional Progress in Engineering Award from the College of Engineering at the Marston Club Dinner on April 18. The award was created to recognize outstanding professional progress, personal development, and distinguished community service by engineering alumni under the age of 46. Berkland is a professor in the ...Calcium-crosslinked LABL-TAT complexes effectively target gene delivery to ICAM-1 expressing cells Supang Khondee1, Abdulgader Baoum1, Teruna J. Siahaan1, and Cory Berkland1,2,* 1Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS 66047 2Department of Chemical and Petroleum Engineering, The University of Kansas, Lawrence, KSIf delivered as a suspension, such small particles are also prone to particle growth due to Ostwald ripening and can suffer from uncontrolled agglomeration (Berkland, 2010). A major obstacle to inhaled therapeutics is the inability to efficiently deliver large quantities of a drug to the deep lung (Gillian, 2010).
Berkland serves as the Chairman of the Board, President, Chief Executive Officer (CEO), and Co-Founder of Bond Biosciences. He is taking a part ial leave as Distinguished Professor at The University of Kansas to advance the business and to ensure the development and clinical trial progression of BBI-001.Bond Biosciences has a strong board and managment team with significant industry experience including Cory Berkland, Mike Riley, Tim Opler and Mike Beckloff.Cory Berkland. E-mail: [email protected]; Vladimir Birman Associate Professor of Chemistry McMillen 409. E-mail: [email protected]; Phone: 314-935-9188 John Bleeke Professor of Chemistry McMillen 501. E-mail: [email protected]; Phone: 314-935-6809 Robert Charity…
Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Cory Berkland is a Professor in the Departmen. Possible cause: BERKLAND CORY, WANG QUN. Author information. Affiliations. All authors. 1. UNIV KA.
1. Peek LJ, Middaugh CR, Berkland C. Nanotechnology in vaccine delivery. Adv Drug Deliv Rev. 2008 May 22; 60(8):915–928. † We reviewed the field of nanotechnology applied to vaccine formulation and delivery in 2008. 2. O’Hagan DT, Fox CB. New generation adjuvants–from empiricism to rational design. Vaccine. 2015 Jun 8; 33(Suppl 2):B14 ...Cory Berkland Professor Biomedical Engineering [email protected] Google Scholar Education PhD, University of Illinois, 2003 MS, University of Illinois, 2001 BS, Iowa State University, 1998 Research areas Advanced Materials Biomedical, Bio-inspired, and Bio-derived Materials Cell & Molecular Bioengineering Regenerative Engineering in Medicine Cory Berkland Date Defended: 11 July 2019. ii The thesis committee for Hao Lou certifies that this is the approved version of the following thesis: The Application of Machine Learning Algorithms in Understanding the Effect of Core/Shell Technique on Improving Powder Compactability
Cory BERKLAND | Cited by 10,026 | of University of Kansas, Kansas (KU) | Read 243 publications | Contact Cory BERKLANDNabil A Alhakamy 1 , David T Curiel 2 , Cory J Berkland 3 Affiliations 1 Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia; ... University of Kansas, Lawrence, KS 66047, USA. Electronic address: [email protected]. PMID: 33781953 DOI: 10.1016/j.drudis.2021.03.021 Abstract
Cory Berkland. Solon E. Summerfield Distinguished Professor CORY BERKLAND. Administrator. See All Contacts. Dynamic search and list-building capabilities. Real-time trigger alerts. Comprehensive company profiles. Valuable research and technology reports. Get a D&B Hoovers Free Trial. Financial Data. Dun & Bradstreet collects private company financials for more than 23 million companies worldwide.Introduction. Advancements in treating autoimmune diseases such as multiple sclerosis (MS) have been made by enhancing our understanding of the molecular processes involved in disease progression. 1,2 The complexity of immune responses and the heterogeneous nature of immune cells complicate the design of therapeutics. In the case of relapsing-remitting MS, the disease state is propagated ... Cory BERKLAND | Cited by 10,026 | of University of Kansas, Kan3. The student ban is cruel. Expelling students in the middl Cory Berkland, distinguished professor of pharmaceutical chemistry and chemical and petroleum engineering. This technology addresses a critical need to develop a more targeted immunotherapy to avoid unwanted immunosuppression and side effects. Antigen-drug conjugates use antigen epitopes specific to the autoimmune disease as agents to deliver ...Purpose Encapsulation of liquids into biodegradable polymer microcapsules has been a challenging task due to production limitations stemming from solution viscosity, phase stabilization, molecular localization, and scalable production. We report an extension of Precision Particle Fabrication (PPF) technology for the production of monodisperse liquid-filled microcapsules containing an oil or ... Author links open overlay panel Emily J. Pollauf a, Cory Be Nabil A Alhakamy 1 , David T Curiel 2 , Cory J Berkland 3 Affiliations 1 Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia; ... University of Kansas, Lawrence, KS 66047, USA. Electronic address: [email protected]. PMID: 33781953 DOI: 10.1016/j.drudis.2021.03.021 AbstractChairperson Dr. Cory Berkland Date Approved: September 18th, 2018 . iii Abstract Autoimmune diseases afflict a significant part of the world population and current treatments only treat symptoms or delay the progression of the disease. In the first chapter of this Cory Berkland, CEO [email protected] Release Summary BoI would like to sincerely and gratefully thank my advisor, Dr. Cory Berkland C, Kim K, Pack DW. Fabrication of Prof. Berkland is a co-founder of Orbis Biosciences, Savara Pharmaceuticals, Bond Biosciences and Orion BioScience. He is also a co-developer of several technologies with industrial partners. He... C. Berkland et al. Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions. J. Controlled Release (2001) ... Cory Berkland. Functions of the plasminogen receptor Plg‐R KT. Journal of Thrombosis and Haemostasis, Volume 18, Issue 10, 2020, pp. 2468-2481. Cory Berkland Songyot Anuchapreeda: Keywords: Agricultural and Bi Congratulations to our collaborator, Prof. Cory Berkland, who was recognized last week with the Jim Baxendale Commercialization Award! Prof. Berkland... Vaccine-like Controlled-Release Delivery[Cory Berkland The University of Kansas Verified Cory Berkland Professor Berkland has garnered international at Introduction. With approximately 174,000 cases per year, luminal breast cancers are the most common forms of breast cancer diagnosed in the US and Canada [1, 2].In contrast to Her2-overexpressing breast cancers, or triple negative breast cancers, which lack expression of estrogen receptor (ER), Progesterone receptor, and Her2, luminal breast cancers frequently express hormone and Her2 ...Vaccine-like Controlled-Release Delivery of an Immunomodulating Peptide to Treat Experimental Autoimmune Encephalomyelitis Barlas Büyüktimkin1, Qun Wang2, Paul Kiptoo1, John M. Stewart1, Cory Berkland1,2, and Teruna J. Siahaan1,* 1Department of Pharmaceutical Chemistry, School of Pharmacy, University of Kansas, Lawrence, KS